McGill Cancer Centre at McGill University

Montreal, Quebec H3H 1P3

0 studies enrolling now · 34 studies all time

What they study most

Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Cervical Cancer, Cognitive/Functional Effects, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor, Graft Versus Host Disease, Head and Neck Cancer

Studies at this site

• Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer — Completed
• High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
• Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis — Completed
• Temozolomide and Radiation Therapy in Treating Patients With Gliomas — Completed
• TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. — Completed
• Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma — Completed
• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer — Completed
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
• Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
• Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
• Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer — Completed
• Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery — Completed
• Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer — Completed
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer — Completed
• Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Status unconfirmed
• Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer — Completed
• Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma — Completed
• Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery — Completed
• Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer — Completed
• Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer — Completed
• Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg — Completed
• Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy — Completed
• Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery — Completed
• Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors — Completed
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
• Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors — Stopped early
• Radiation Therapy in Treating Patients With Liver Metastases — Completed
• Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer — Completed
• S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML — Completed
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes — Completed
• Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy — Completed
• Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease — Completed
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma — Completed
• Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer — Completed